Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
7.93
+1.18 (17.48%)
At close: Nov 19, 2026, 4:00 PM EST
8.48
+0.55 (6.94%)
After-hours: Nov 19, 2026, 7:46 PM EST
Moleculin Biotech Market Cap
Moleculin Biotech has a market cap or net worth of $7.72 million as of November 19, 2026. It is the 42,573rd most valuable company in the world and the 5,632nd biggest in the United States. Its market cap has decreased by 64.25% in one year.
Market Cap
7.72M
Enterprise Value
542.78K
1-Year Change
-64.25%
Global Rank
Country Rank
#5,632 United States
Category
ChartMarket Cap Chart
Since June 2, 2016, Moleculin Biotech's market cap has decreased from $70.60M to $7.72M, a decrease of -89.06%. That is a compound annual growth rate of -19.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 7.20M | 7.46% |
| Dec 31, 2025 | 6.70M | 31.37% |
| Dec 31, 2024 | 5.10M | -80.08% |
| Dec 29, 2023 | 25.60M | -15.51% |
| Dec 30, 2022 | 30.30M | -42.94% |
| Dec 31, 2021 | 53.10M | 6.63% |
| Dec 31, 2020 | 49.80M | 19.14% |
| Dec 31, 2019 | 41.80M | 48.23% |
| Dec 31, 2018 | 28.20M | -28.24% |
| Dec 29, 2017 | 39.30M | 42.91% |
| Dec 30, 2016 | 27.50M | -61.05% |
| Jun 2, 2016 | 70.60M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IN8bio | 8.35M |
| Vistagen Therapeutics | 8.28M |
| Chemomab Therapeutics | 8.26M |
| Intensity Therapeutics | 8.25M |
| Lisata Therapeutics | 8.20M |
| CalciMedica | 8.07M |
| Immuron | 7.97M |
| Aligos Therapeutics | 7.81M |